Business Context and Reporting Period
Company: DENTSPLY International Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: The Company is the world's largest designer, developer, and manufacturer of professional dental products, operating in over 120 countries. Its principal product categories include dental consumables, dental laboratory products, and dental specialty products (endodontics, implants, orthodontics).
Key Financial Metrics
| Metric (in millions) | Q3 2009 | Q3 2008 | 9 Months 2009 | 9 Months 2008 |
|---|---|---|---|---|
| Net Sales | $531.0 | $530.0 | $1,591.2 | $1,685.6 |
| Gross Profit | $273.0 | $280.2 | $826.9 | $880.9 |
| Operating Income | $92.9 | $80.9 | $277.8 | $295.1 |
| Net Income (Attributable to DENTSPLY) | $67.5 | $66.0 | $199.4 | $212.9 |
| Diluted EPS | $0.45 | $0.44 | $1.33 | $1.40 |
| Cash from Operations (9 Months) | - | $245.4 | $236.8 | |
| Cash & Equivalents (End of Period) | - | $333.4 | $54.2 | |
| Total Debt (Current + Long-term) | - | $395.2 | $449.5 |
Note: Debt figures represent carrying value. Current portion of long-term debt increased significantly in 2009 due to reclassification of maturing facilities.
Material Changes vs. Prior Period
- Revenue: Net sales were flat in Q3 2009 (+0.2%) but declined 5.6% for the nine-month period. Excluding precious metal content, sales grew 1.1% in Q3 but declined 3.6% year-to-date. Declines were driven by unfavorable currency translation, dealer inventory reductions, and weakness in non-dental and laboratory products.
- Profitability: Operating income increased 14.8% in Q3 2009 compared to Q3 2008, primarily due to a significant reduction in "Restructuring, impairments and other costs" (down from $18.5M to $1.2M). However, operating income for the nine-month period decreased 5.9%.
- Gross Margin: Gross profit margin (excluding precious metals) decreased 2.1 percentage points in Q3 and 1.5 percentage points year-to-date due to unfavorable sales mix, lower production volumes, and currency impacts.
- Liquidity: Cash and cash equivalents increased significantly from $204.0M at year-end 2008 to $333.4M at September 30, 2009, driven by strong operating cash flow and reduced capital expenditures.
- Debt Structure: Long-term debt decreased by $54.3M year-to-date. However, $240.4M of debt is now classified as current liabilities due to the maturity of credit facilities in May 2010.
Guidance, Outlook, and Risks
- Outlook: Management expects to realize full cost savings from restructuring plans initiated in late 2008 and early 2009 during 2010. The Company anticipates continued pressure from the economic environment but expects the dental market to perform better than the overall economy.
- Capital Allocation: The Company continues to repurchase shares (723,700 shares purchased in the first nine months of 2009) and pay dividends ($0.15 per share year-to-date).
- Refinancing: On October 16, 2009, the Company entered into an agreement to issue $250.0 million of 4.11% Senior Notes to refinance a $150.0 million note maturing in March 2010 and for general corporate purposes.
- Legal Contingencies:
- Guidance Endodontics: A jury returned a verdict against DENTSPLY on October 9, 2009, for approximately $44.0 million ($4.0M compensatory, $40.0M punitive). The Company intends to appeal and does not believe the outcome will have a material adverse effect.
- Antitrust Litigation: Ongoing appeals regarding tooth distribution practices and resale price maintenance claims.
- Product Liability: Class action suits regarding Cavitron ultrasonic scalers remain pending in California and Pennsylvania/New Jersey.
- Market Risks: Significant exposure to foreign currency fluctuations (approx. 60% of sales outside the U.S.) and commodity prices (precious metals), though hedging strategies are in place.
Investor Verification Checklist
- Debt Maturity: Verify the status of the $250M Senior Note issuance to refinance the $150M note maturing March 15, 2010, and the $500M revolving credit facility maturing May 2010.
- Legal Exposure: Monitor the appeal process for the $44M Guidance Endodontics verdict and the status of the antitrust class action appeals scheduled for January 2010.
- Inventory Levels: Assess the impact of dealer inventory reductions on future sales growth, particularly in emerging markets.
- Currency Hedging: Review the effectiveness of net investment hedges and foreign exchange forward contracts given the volatility in the Euro and Yen.
- Restructuring Savings: Track the realization of cost savings from the 2008/2009 restructuring plans to confirm the projected margin improvements in 2010.